TABLE 1.
Source information for the 28 D. pigrum strains and quality description for the 17 newly SMRT-sequenced closed genomesa
| Original strain name | Internal reference | Yr isolated | Human body site | Location | Age (yrs) | NCBI assembly ID | Source or reference | Realigned bases (%)b | Coverage (fold) |
|---|---|---|---|---|---|---|---|---|---|
| ATCC 51524 | NA | 1988 | Spinal cord | UK | ? | GCF_000245815.1 | 135 | ||
| KPL1914 | KPL1914 | 2010 | Nostril | MA | Adult | GCA_003263915.2 | 28 | ||
| CDC39-95 | KPL1922 | 1995 | NP | CN | 3 | GCF_003264145.1 | 48 | ||
| CDC2949-98 | KPL1930 | 1998 | NP | AZ | ? | GCF_003264135.1 | 48 | ||
| CDC4294-98 | KPL1931 | 1998 | Blood | SC | <1 | GCF_003264085.1 | 48 | ||
| CDC4420-98 | KPL1932 | 1998 | Blood | TN | 11 | GCF_003264065.1 | 48 | ||
| CDC4545-98 | KPL1933 | 1998 | NP | AZ | ? | GCF_003264045.1 | 48 | ||
| CDC4709-98 | KPL1934 | 1998 | Eye | GA | <1 | GCA_003264015.2 | 48 | ||
| CDC4199-99 | KPL1937 | 1999 | Blood | GA | ∼2 | GCF_003264005.1 | 48 | ||
| CDC4791-99 | KPL1938 | 1999 | NP | AZ | ? | GCF_003263975.1 | 48 | ||
| CDC4792-99 | KPL1939 | 1999 | NP | AZ | ? | GCF_003263965.1 | 48 | ||
| KPL3033 | KPL3033 | 2018 | Nostril | MA | 18–30 | GCA_017655925.1 | This study | 92.61* | 498 |
| KPL3043 | KPL3043 | 2018 | Nostril | MA | 7–12 | GCA_017655905.1 | This study | 92.40* | 582 |
| KPL3050 | KPL3050 | 2018 | Nostril | MA | 31–60 | GCA_017655885.1 | This study | 92.11* | 475 |
| KPL3052 | KPL3052 | 2018 | Nostril | MA | 3–6 | GCA_017655865.1 | This study | 92.15* | 382 |
| KPL3065 | KPL3065 | 2018 | Nostril | MA | 7–12 | GCA_017655845.1 | This study | 91.73* | 460 |
| KPL3069 | KPL3069 | 2018 | Nostril | MA | 7–12 | GCA_017655825.1 | This study | 88.13* | 372 |
| KPL3070 | KPL3070 | 2018 | Nostril | MA | 31–60 | GCA_017655785.1 | This study | 91.85* | 271 |
| KPL3077 | KPL3077 | 2018 | Nostril | MA | 7–12 | GCA_017655765.1 | This study | 91.60 | 351 |
| KPL3084 | KPL3084 | 2018 | Nostril | MA | 31–60 | GCA_017655745.1 | This study | 90.24* | 433 |
| KPL3086 | KPL3086 | 2018 | Nostril | MA | <3 | GCA_017655725.1 | This study | 91.30* | 342 |
| KPL3090 | KPL3090 | 2018 | Nostril | MA | 7–12 | GCA_017655685.1 | This study | 90.72* | 423 |
| KPL3246 | KPL3246 | 2018 | Nostril | MA | 7–12 | GCA_017655805.1 | This study | 92.47* | 578 |
| KPL3250 | KPL3250 | 2018 | Nostril | MA | 7–12 | GCA_017655665.1 | This study | 92.63* | 501 |
| KPL3256 | KPL3256 | 2018 | Nostril | MA | 7–12 | GCA_017655645.1 | This study | 92.84 | 530 |
| KPL3264 | KPL3264 | 2018 | Nostril | MA | 7–12 | GCA_017655705.1 | This study | 87.61 | 342 |
| KPL3274 | KPL3274 | 2018 | Nostril | MA | 7–12 | GCA_017655945.1 | This study | 87.41* | 574 |
| KPL3911 | KPL3911 | 2017 | Nostril | MA | <3 | GCA_017655965.1 | This study | 87.13* | 595 |
a
NA, not applicable; NP, nasopharynx.
b
Percent realigned bases (from Realignment to Draft Assembly). *, circularized genome.